Serotonin syndrome (Q88271): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
A síndrome serotoninérgica é caracterizada por um excesso de serotonina no sistema nervoso central, associado ao uso de vários agentes, incluindo inibidores seletivos da recaptação da serotonina (ISRS). A síndrome serotoninérgica pode resultar em rigidez muscular, mioclonia, agitação, confusão, hipertermia, hiperreflexia, bem como sintomas disautonômicos, com risco de choque com baixa resistência vascular periférica, convulsões, coma, rabdomiólise e / ou coagulação intravascular disseminada (CIVD). | |||
| description / en | description / en | ||
Serotoninergic syndrome is characterised by an excess of serotonin in the central nervous system, associated with the use of various agents, including selective serotonin reuptake inhibitors (SSRIs). Serotoninergic syndrome may result in muscle rigidity, myoclonus, agitation, confusion, hyperthermia, hyperreflexia as well as dysautonomic symptoms, with a risk of shock with low peripheral vascular resistance, seizures, coma, rhabdomyolysis and/or disseminated intravascular coagulation (DIC). | |||
Revision as of 14:27, 15 August 2026
Serotoninergic syndrome is characterised by an excess of serotonin in the central nervous system, associated with the use of various agents, including selective serotonin reuptake inhibitors (SSRIs). Serotoninergic syndrome may result in muscle rigidity, myoclonus, agitation, confusion, hyperthermia, hyperreflexia as well as dysautonomic symptoms, with a risk of shock with low peripheral vascular resistance, seizures, coma, rhabdomyolysis and/or disseminated intravascular coagulation (DIC).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_678764364 |
||
| English | Serotonin syndrome |
Serotoninergic syndrome is characterised by an excess of serotonin in the central nervous system, associated with the use of various agents, including selective serotonin reuptake inhibitors (SSRIs). Serotoninergic syndrome may result in muscle rigidity, myoclonus, agitation, confusion, hyperthermia, hyperreflexia as well as dysautonomic symptoms, with a risk of shock with low peripheral vascular resistance, seizures, coma, rhabdomyolysis and/or disseminated intravascular coagulation (DIC). |
